May 15 (Reuters)-
Sundrug Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2025 Mar 31, 2024 Mar 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 801.81 751.78 850.00 419.20
(+6.7 pct) (+8.9 pct) (+6.0 pct) (+6.0 pct)
Operating 44.50 41.00 47.30 23.10
(+8.5 pct) (+9.5 pct) (+6.3 pct) (+8.9 pct)
Recurring 43.84 41.73 46.00 22.35
(+5.0 pct) (+9.4 pct) (+4.9 pct) (+7.3 pct)
Net
Net 30.75 29.13 31.70 15.35
(+5.6 pct) (+13.3 pct) (+3.1 pct) (+7.6 pct)
EPS 262.91 yen 249.07 yen 271.03 yen 131.24 yen
Ann Div 130.00 yen 114.00 yen 131.00 yen
-Q2 Div 65.00 yen 57.00 yen 65.00 yen
-Q4 Div 65.00 yen 57.00 yen 66.00 yen
NOTE - Sundrug Co Ltd.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9989.T